Colloidal Nanocarriers as Versatile Targeted Delivery Systems for Cervical Cancer

Area of Science:

• Oncology
• Nanotechnology
• Drug Delivery

Background:

• Cervical cancer is a leading cause of cancer death globally, particularly in developing nations.
• Conventional treatments cause severe side effects, toxicity, multidrug resistance (MDR), and poor outcomes.
• Current therapies lack specificity, damaging both cancerous and healthy tissues.

Purpose of the Study:

• To review current cervical cancer treatment challenges.
• To explore the potential of colloidal nanocarriers for targeted drug delivery in cervical cancer.

Main Methods:

• Literature review of colloidal nanocarrier applications in cervical cancer.
• Survey of various nanocarrier types including nanoemulsions, nanodispersions, polymeric, and metallic nanoparticles.
• Inclusion of photothermal and photodynamic therapy approaches.

Main Results:

• Significant advancements have been made in nanocarrier-based cervical cancer treatment.
• Various colloidal nanocarriers show promise for targeted delivery.
• The study identified key nanocarrier types and therapeutic modalities.

Conclusions:

• Colloidal nanocarriers offer potential for targeted cervical cancer treatment with reduced side effects and lower MDR incidence.
• This approach may improve patient survival rates.
• Future research should address regulatory hurdles and cost-effectiveness for clinical application.